SCIENCE 37

News

 
SCIENCE 37

News

 
Science 37 related announcements, media, stories, and more.
New Science 37® Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize
New Science 37® Report: Nearly 100% of Biopharma…
As decentralized clinical trial technologies and methods rapidly expand, advances…
/Company/News/New-Science-37-sup-%C2%AE-sup-Report-Nearly-100-of-Biopharma-Executives-Expect-Clinical-Trial-Decent
Science 37<sup>®</sup> to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future
Science 37® to Become Publicly Listed via Merger…
Transaction values Science 37 at an enterprise value of approximately $1.05 billion…
/Company/News/Science-37-sup-reg%3B-sup-to-Become-Publicly-Listed-via-Merger-with-LifeSci-Acquisition-II-Corp-%2C-P
PPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate Development
PPD and Science 37® Strengthen Collaboration to…
Innovative approach enables PPD to deploy studies utilizing Science 37's SaaS…
/Company/News/PPD-and-Science-37-sup-reg%3B-sup-Strengthen-Collaboration-to-Advance-Decentralized-Clinical-Trial
Syneos Health® Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
Syneos Health® Partners with Science 37® to…
Science 37’s Technology-First Operating System Further Powers Syneos Health’s…
/Company/News/Syneos-Health-sup-reg%3B-sup-Partners-with-Science-37-sup-reg%3B-sup-to-Transform-Clinical-Trials
Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
Science 37® and Xperiome™ Partner to Increase the…
Using Science 37’s decentralized clinical trial model, the partnership offers…
/Company/News/Science-37-sup-reg%3B-sup-and-Xperiome-sup-trade%3B-sup-Partner-to-Increase-the-Efficiency-and-Spe
Science 37® and Medgate Partner to Further Globalize Decentralized Clinical Trials
Science 37® and Medgate Partner to Further…
With a presence in Europe, Asia-Pacific, and the Middle East, Medgate extends the…
/Company/News/Science-37-sup-reg%3B-sup-and-Medgate-Partner-to-Further-Globalize-Decentralized-Clinical-Trials
Science 37® and Signant Health Partner to Expand Access to CNS Research with Decentralized Clinical Trials
Science 37® and Signant Health Partner to Expand…
Collaboration enables patients to participate in clinical trials from their homes—…
/Company/News/Science-37-sup-reg%3B-sup-and-Signant-Health-b-Partner-to-Expand-Access-to-CNS-Research-with-Dece
Join Science 37 and a Panel of Industry Leaders for a Pragmatic Discussion about “What it Takes to Truly Empower Diversity in Clinical Trials”
Join Science 37® and a Panel of Industry Leaders…
The webinar will feature leaders from Novartis, PPD, National Urban League,…
/News/Join-Science-37-and-a-Panel-of-Industry-Leaders-for-a-Pragmatic-Discussion
Science 37® Supports DCRI's First Direct-to-Family Study for Pediatric Lupus
Science 37® Supports DCRI's First Direct-to-…
Science 37 is excited to be part of the first-of-its-kind direct-to-family study…
/Company/News/Science-37-sup-reg%3B-sup-Supports-DCRI-s-First-Direct-to-Family-Study-for-Pediatric-Lupus-en
Science 37® Integrates Electronic Health Records into Its Decentralized Clinical Trial Technology Platform
Science 37® Integrates Electronic Health Records…
Patients using Science 37’s technology platform can now connect their health record…
/Company/News/Science-37-sup-reg%3B-sup-Integrates-Electronic-Health-Records-into-Its-Decentralized-Clinical-Tria-en
John Hubbard, Ph.D., Joins Science 37® Board of Directors
John Hubbard, Ph.D., Joins Science 37® Board of…
Science 37, the industry leader in decentralized clinical trials, today announced…
/Company/News/John-Hubbard%2C-Ph-D-%2C-Joins-Science-37-sup-reg%3B-sup-Board-of-Directors
Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market
Science 37® Raises $40 Million to Extend Its…
In a significantly oversubscribed offering, Science 37 attracted capital to support…
/Company/News/Science-37-sup-reg%3B-sup-Raises-%2440-Million-to-Extend-Its-Leadership-in-the-Decentralized-Clinical